Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Efficacy of Allogenic Stem Cell Transplant in KMT2A Partial Tandem Duplication ( -PTD) Myeloid Neoplasms | Synapse
March 3, 2026
Efficacy of Allogenic Stem Cell Transplant in KMT2A Partial Tandem Duplication ( -PTD) Myeloid Neoplasms
PA
Peter Abdelmessieh
BS
Bhaumik Shah
Fox Chase Cancer Center
YS
Yuliya Shestovska
Fox Chase Cancer Center
Ver todo
Puntos clave
Efficacy of allogenic stem cell transplant shows promise in treating myeloid neoplasms associated with KMT2A alterations.
Patients with KMT2A partial tandem duplication may respond positively to this transplant approach, enhancing survival.
Assessment based on patient records indicates significant outcomes following intervention over a specified follow-up period.
Findings highlight the need for further exploration into stem cell interventions for specific myeloid neoplasms.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Abdelmessieh et al. (Sun,) studied this question.
synapsesocial.com/papers/69a760b9c6e9836116a2dbb0
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.159